RareAgent: Self-Evolving Reasoning for Drug Repurposing in Rare Diseases
By: Lang Qin , Zijian Gan , Xu Cao and more
Potential Business Impact:
Finds new uses for old medicines for rare sicknesses.
Computational drug repurposing for rare diseases is especially challenging when no prior associations exist between drugs and target diseases. Therefore, knowledge graph completion and message-passing GNNs have little reliable signal to learn and propagate, resulting in poor performance. We present RareAgent, a self-evolving multi-agent system that reframes this task from passive pattern recognition to active evidence-seeking reasoning. RareAgent organizes task-specific adversarial debates in which agents dynamically construct evidence graphs from diverse perspectives to support, refute, or entail hypotheses. The reasoning strategies are analyzed post hoc in a self-evolutionary loop, producing textual feedback that refines agent policies, while successful reasoning paths are distilled into transferable heuristics to accelerate future investigations. Comprehensive evaluations reveal that RareAgent improves the indication AUPRC by 18.1% over reasoning baselines and provides a transparent reasoning chain consistent with clinical evidence.
Similar Papers
RareAgent: Self-Evolving Reasoning for Drug Repurposing in Rare Diseases
Artificial Intelligence
Finds new uses for old medicines for rare sicknesses.
Learning to reason about rare diseases through retrieval-augmented agents
Computation and Language
Helps doctors find rare diseases in brain scans.
A Specialized Large Language Model for Clinical Reasoning and Diagnosis in Rare Diseases
Computation and Language
Helps doctors find rare diseases faster.